首页> 美国卫生研究院文献>Diabetes Therapy >Which Patients Will Benefit from a Switch in Therapy from Premixed Insulin to Insulin Glargine plus Oral Antidiabetic Drugs? Further Analysis of the Lantus Registry Study

【2h】

Which Patients Will Benefit from a Switch in Therapy from Premixed Insulin to Insulin Glargine plus Oral Antidiabetic Drugs? Further Analysis of the Lantus Registry Study

机译：哪些患者将从预混合胰岛素改为甘精胰岛素加口服降糖药的治疗中受益？ Lantus Registry研究的进一步分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

IntroductionThis subgroup analysis of data from the 16-week Lantus Registry Study in China investigated the characteristics of patients with type 2 diabetes mellitus (T2DM) associated with clinical benefits of transitioning therapy from premixed insulin to insulin glargine (100 U/ml) plus oral antidiabetic drugs (OADs).

机译：简介这项来自中国的为期16周的Lantus Registry研究的数据的亚组分析调查了2型糖尿病（T2DM）患者的特征，这些特征与将预混合胰岛素过渡到甘精胰岛素（100 U / ml）加口服降糖药的临床益处有关药物（OAD）。

著录项

期刊名称 Diabetes Therapy
作者
Shi Bu; Xuelian Zhang; Haiqing Zhu; Ying Shuai; Xiaoyan Xing; Wenying Yang;
展开▼
作者单位

展开▼
年(卷),期 2017(8),4
年度 2017
页码 887–898
总页数 12
原文格式 PDF
正文语种
中图分类基础医学;
关键词
Insulin glargine Oral antidiabetic drugs Premixed insulin Type 2 diabetes mellitus;

机译：甘精胰岛素;口服降糖药;预混胰岛素;2型糖尿病;

相似文献

外文文献
中文文献
专利

1. Which Patients Will Benefit from a Switch in Therapy from Premixed Insulin to Insulin Glargine plus Oral Antidiabetic Drugs? Further Analysis of the Lantus Registry Study [J] . Shi Bu, Xuelian Zhang, Haiqing Zhu, Diabetes therapy . 2017,第4期

机译：哪些患者将从预混合胰岛素改为甘精胰岛素加口服降糖药的治疗中受益？ Lantus Registry研究的进一步分析
2. Efficacy and treatment satisfaction of once-daily insulin glargine plus one or two oral antidiabetic agents versus continuing premixed human insulin in patients with Type 2 diabetes previously on long-term conventional insulin therapy: the SWITCH Pil [J] . Schiel R, Muller UA Experimental and clinical endocrinology and diabetes: Official journal, German Society of Endocrinology [and] German Diabetes Association . 2008,第1期

机译：与以前长期接受常规胰岛素治疗的2型糖尿病患者相比，每日一次甘精胰岛素加一或两种口服降糖药与持续预混人胰岛素的疗效和治疗满意度：SWITCH Pil
3. Efficacy and treatment satisfaction of once-daily insulin glargine plus one or two oral antidiabetic agents versus continuing premixed human insulin in patients with type 2 diabetes previously on long-term conventional insulin therapy: the Switch pil [J] . Schiel R, Muller UA Experimental and clinical endocrinology and diabetes: Official journal, German Society of Endocrinology [and] German Diabetes Association . 2007,第10期

机译：与以前长期接受常规胰岛素治疗的2型糖尿病患者相比，每日一次甘精胰岛素加一或两种口服降糖药与持续预混人胰岛素的疗效和治疗满意度：Switch pil
4. Switching to insulin glargine 300 U/mL from other basal insulin analogues provides less 24-hour glucose variability in hospitalized patients with type 1 diabetes [C] . V.V. Klimontov, E.A. Koroleva, O.N. Fazullina International Multiconference Bioinformatics of Genome Regulation and StructureSystems Biology . 2018

机译：从其他基础胰岛素类似物转换为甘精胰岛素300 U / mL可使住院的1型糖尿病患者的24小时葡萄糖变异性降低
5. Physiology and pharmacology of diabetes therapies in the cat: Insulin detemir, insulin glargine, exenatide and the incretin effect. [D] . Gilor, Chen. 2010

机译：猫的糖尿病疗法的生理和药理作用：地特胰岛素，甘精胰岛素，艾塞那肽和肠降血糖素作用。
6. Real-world outcomes of initiating insulin glargine-based treatment versus premixed analog insulins among US patients with type 2 diabetes failing oral antidiabetic drugs [O] . Onur Baser, Krishna Tangirala, Wenhui Wei, 2013

机译：在美国2型糖尿病口服抗糖尿病药物治疗失败的患者中开始使用基于甘精胰岛素的治疗与预混合类似胰岛素的实际结果
7. Insulin glargine compared with premixed insulin for management of insulin-naïve type 2 diabetes patients uncontrolled on oral antidiabetic drugs: the open-label, randomized GALAPAGOS study [O] . Aschner Pablo, Sethi Bipin, Gomez-Peralta Fernando, 2015

机译：甘精胰岛素与预混合胰岛素治疗未使用口服降糖药的未接受胰岛素治疗的2型糖尿病患者：开放标签，随机GALAPAGOS研究

Which Patients Will Benefit from a Switch in Therapy from Premixed Insulin to Insulin Glargine plus Oral Antidiabetic Drugs? Further Analysis of the Lantus Registry Study

摘要

著录项

相似文献

相关主题

期刊订阅